Skip to content

Comparison of Volulyte® versus Tetraspan® in patients undergoing cardiopulmonary bypass.

Comparison of Volulyte® versus Tetraspan® in patients undergoing cardiopulmonary bypass. - Comparison of Volulyte® versus Tetraspan®

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-003321-99-BE
Enrollment
Unknown
Registered
2012-02-07
Start date
2012-03-02
Completion date
Unknown
Last updated
2015-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coagulation status, colloid oncotic pressure (COP) and ion- and acid-base balance.

Interventions

Trade Name: Tetraspan ® Pharmaceutical Form: Solution for infusion CAS Number: 8000006-02-2 Other descriptive name: STARCH POTATO Trade Name: Volulyte® Pharmaceutical Form: Solution for infusion CAS

Sponsors

UZ Brussels
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients undergoing cardiac surgery with cardiopulmonary bypass. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 30

Exclusion criteria

Exclusion criteria: Patients with preoperative, renal failure, urgent and redo operations, IABP

Design outcomes

Primary

MeasureTime frame
Main Objective: Does the use of two different balanced hydroxyethyl starch solutions, influence the coagulation profile, acid-base status, ionogram, colloid oncotic pressure?;Secondary Objective: Safety profile and outcome;Primary end point(s): Coagulation profile, acid-base status, ionogram, colloid oncotic pressure.;Timepoint(s) of evaluation of this end point: Induction of anesthesia, on CBP, after CBP and POD1

Secondary

MeasureTime frame
Secondary end point(s): Organ function and outcome.;Timepoint(s) of evaluation of this end point: POD1

Countries

Belgium

Contacts

Public ContactPerfusion

UZ Brussel

luc.puis@uzbrussel.be003224763618

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026